Welcome to our dedicated page for Astrana Health news (Ticker: $ASTH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Astrana Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Astrana Health's position in the market.
Astrana Health, Inc. reported strong financial results for the first quarter of 2024, with revenue growth of 20%, net income up 13%, and adjusted EBITDA rising by 42% compared to the previous year. The company saw solid membership growth, totaling approximately one million lives managed. Astrana successfully closed major acquisitions, enabling it to take on more responsibilities and expand its services. The company is on track to continue its growth trajectory throughout the year.
Astrana Health, Inc. has scheduled the release of its 2024 first-quarter financial results for March 31, 2024, after the stock market closes on May 7, 2024. The company will host a conference call on the same day at 2:30 p.m. PT/5:30 p.m. ET to discuss the results. Participant dial-in numbers are (888-437-3179) or (862-298-0702).
